Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Intussusception

Treatments: Other: Screening sheets

Study type: Observational

Funder types: Industry

Identifiers

NCT01177839

999910/193

Details and patient eligibility

About

This prospective study aims to estimate the incidence of intussusception among children < 2 years old through hospital-based surveillance in Singapore.

Enrollment: 178 patients

Sex: All

Ages: Under 24 months old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A male or female infant aged < 24months at the time of diagnosis of intussusception.
• Subject is diagnosed with definite, probable, possible, suspected intussusception during the period of at least one year beginning at study start.
• Written informed consent obtained from the parent or guardian of the subject.

Exclusion criteria

• A male or female infant ≥ 24 months of age at the time of intussusception diagnosis.
• The subject has had a radiographically or surgically confirmed case of intussusception prior to the current episode.

Trial design

178 participants in 1 patient group

Intussusception cohort

Description:

Subjects with Intussusception

Treatment:

Other: Screening sheets